Lixte Biotechnology Holdings, Inc.
Hedge Funds Holdings

Last updated:

Lixte Biotechnology Holdings, Inc.‘s stocks are currently a part of 4 hedge funds’ portfolios, which represents 1.93% of the total amount of its stocks outstanding. This makes up a total of 259.56K shares of Lixte Biotechnology Holdings, Inc.. Compared to the previous quarter, the number fell by -62.19% or -426.98K shares fewer. As for the holding position changes, 50% (2) of current hedge fund investors increased the number of shares held, 25% (1) of current holders sold a part of the shares held, and 50% (2) closed the holdings completely.

Hedge funds holding Lixte Biotechnology Holdings (Q4 2020 – Q1 2023)

Number of hedge funds
Q4 2020 3
Q1 2021 7
Q2 2021 10
Q3 2021 9
Q4 2021 10
Q1 2022 11
Q2 2022 14
Q3 2022 13
Q4 2022 14
Q1 2023 4

Hedge funds changes in Lixte Biotechnology Holdings positions (Q4 2020 – Q1 2023)

Changes in positions
Q4 2020 30000
Q1 2021 6002-1
Q2 2021 42310
Q3 2021 23130
Q4 2021 15202
Q1 2022 22412
Q2 2022 52421
Q3 2022 15124
Q4 2022 41333
Q1 2023 0212-1

Top 50 hedge fund holders of Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT)

Hedge fund Value Shares owned Portfolio share
SANTA MONICA PARTNERS LP 93K 166.66K 0.070%
SABBY MANAGEMENT, LLC 56K 99.64K 0.071%
RENAISSANCE TECHNOLOGIES LLC Jim Simons 51K 90.66K 0.000%
VANGUARD GROUP INC 45K 81.13K 0.000%
MORGAN STANLEY 40K 71.05K 0.000%
STATE STREET CORP 20K 35.95K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 14K 25.79K 0.000%
TWO SIGMA INVESTMENTS, LP John Overdeck 12K 21.27K 0.000%
JANE STREET GROUP, LLC 9K 15.29K 0.000%
WARBERG ASSET MANAGEMENT LLC 8K 14.5K 0.001%
VIRTU FINANCIAL LLC 7K 12.78K 0.001%
TOWER RESEARCH CAPITAL LLC (TRC) 4K 6.92K 0.000%
UBS GROUP AG 4K 7.17K 0.000%
CITADEL ADVISORS LLC Ken Griffin 0 0 0.000%
ALMANACK INVESTMENT PARTNERS, LLC. 0 0 0.000%